CoChat

Plant-made polio type 3 stabilized VLPs-a candidate synthetic polio vaccine

Open access

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

Poliovirus (PV) is the causative agent of poliomyelitis, a crippling human disease known since antiquity. PV occurs in two distinct antigenic forms, D and C, of which only the D form elicits a robust neutralizing response. Developing a synthetically produced stabilized virus-like particle (sVLP)-based vaccine with D antigenicity, without the drawbacks of current vaccines, will be a major step towards the final eradication of poliovirus. Such a sVLP would retain the native antigenic conformation and the repetitive structure of the original virus particle, but lack infectious genomic material. In this study, we report the production of synthetically stabilized PV VLPs in plants. Mice carrying the gene for the human PV receptor are protected from wild-type PV when immunized with the plant-made PV sVLPs. Structural analysis of the stabilized mutant at 3.6 Å resolution by cryo-electron microscopy and single-particle reconstruction reveals a structure almost indistinguishable from wild-type PV3.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-017-00090-w

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Production of PV3 VLPs in plants. a N. benthamiana leaf 6 days after infiltration expressing PV sVLPs suffering severe necrosis from the high levels of 3CD. b Infiltrated N. benthamiana leaf 6 days after infiltration expressing PV sVLPs using the downregulated 3CD. c Western blot analysis of sucrose cushioned sample showing the strongest signal for VP1 in the 70% sucrose interface (IF). d Nycodenz gradient demonstrating the separation of the PV3 SktSC8 VLPs (top band) from contamination. e Western blot of Nycodenz gradient confirming that the top gray band contains most VP1. The lanes with the pre-stained size markers and the positive control (C+) have been duplicated in c and e as all the samples were originally analyzed on the same gel (Supplementary Fig. 1)
Fig. 1 Production of PV3 VLPs in plants. a N. benthamiana leaf 6 days after infiltration expressing PV sVLPs suffering severe necrosis from the high levels of 3CD. b Infiltrated N. benthamiana leaf 6 days after infiltration expressing PV sVLPs using the downregulated 3CD. c Western blot analysis of sucrose cushioned sample showing the strongest signal for VP1 in the 70% sucrose interface (IF). d Nycodenz gradient demonstrating the separation of the PV3 SktSC8 VLPs (top band) from contamination. e Western blot of Nycodenz gradient confirming that the top gray band contains most VP1. The lanes with the pre-stained size markers and the positive control (C+) have been duplicated in c and e as all the samples were originally analyzed on the same gel (Supplementary Fig. 1)CC BY · PubMed Central
Fig. 2 Electron microscope analysis of plant-produced PV VLPs. a N. benthamiana produced wt PV3 VLPs and b PV3 SktSC8 sVLPs visualized by negative staining and TEM. The inset in a represents a higher magnification image of a particle within the main field
Fig. 2 Electron microscope analysis of plant-produced PV VLPs. a N. benthamiana produced wt PV3 VLPs and b PV3 SktSC8 sVLPs visualized by negative staining and TEM. The inset in a represents a higher magnification image of a particle within the main fieldCC BY · PubMed Central
Fig. 3 Structure determination of PV3 sVLPs. a Cryo-EM image of PV3 SktSC8 VLPs in vitreous ice. Examples of some VLPs are highlighted with black arrows. Scale bar, 50 nm. b 3D reconstruction of PV3 SktSC8 sVLP at 3.6 Å resolution, viewed along the two-fold axis. The surface is colored by radius from the center of the VLP from blue through green to red from the highest to the lowest radius. c A central slice through the VLP to show the empty internal surface viewed along the two-fold axis and colored as in b. d Cryo-EM density map at 3.6 Å resolution of PV3 SktSC8 sVLP looking at the VP1 protein pocket. VP1 is shown as sticks with carbon atoms colored yellow, nitrogen atoms in blue and oxygen in red. e Cryo-EM density map at 4.1 Å resolution of the PV3 SktSC8 sVLP with GPP3 pocket factor compound bound to the VP1 protein pocket. VP1 is shown as sticks and colored as in d. The GPP3 molecule is colored in green. Cryo-EM density maps are contoured at 1.0σ
Fig. 3 Structure determination of PV3 sVLPs. a Cryo-EM image of PV3 SktSC8 VLPs in vitreous ice. Examples of some VLPs are highlighted with black arrows. Scale bar, 50 nm. b 3D reconstruction of PV3 SktSC8 sVLP at 3.6 Å resolution, viewed along the two-fold axis. The surface is colored by radius from the center of the VLP from blue through green to red from the highest to the lowest radius. c A central slice through the VLP to show the empty internal surface viewed along the two-fold axis and colored as in b. d Cryo-EM density map at 3.6 Å resolution of PV3 SktSC8 sVLP looking at the VP1 protein pocket. VP1 is shown as sticks with carbon atoms colored yellow, nitrogen atoms in blue and oxygen in red. e Cryo-EM density map at 4.1 Å resolution of the PV3 SktSC8 sVLP with GPP3 pocket factor compound bound to the VP1 protein pocket. VP1 is shown as sticks and colored as in d. The GPP3 molecule is colored in green. Cryo-EM density maps are contoured at 1.0σCC BY · PubMed Central
Fig. 4 Stabilizing mutations in PV3 sVLPs. a Mutations in the PV3 SktSC8 sVLP compared to wt sequence. Panels show a snapshot of cryo-EM density for each of the mutations present in the PV3 SktSC8 sVLP. Wt residues are shown as sticks colored orange, with mutated residues observed in the 3.6 Å cryo-EM map as green. Cryo-EM density maps are contoured at 1.0σ. b Cartoon representation of the asymmetric unit for the PV3 SktSC8 sVLP. Individual subunits of the protomer are colored blue (VP1), green (VP2), red (VP3) and yellow (VP4). Mutations are shown as spheres and colored magenta. The position of the GPP3 molecule observed bound to the VP1 protein pocket of the 4.1 Å structure of PV3 SktSC8 sVLP is shown as orange spheres
Fig. 4 Stabilizing mutations in PV3 sVLPs. a Mutations in the PV3 SktSC8 sVLP compared to wt sequence. Panels show a snapshot of cryo-EM density for each of the mutations present in the PV3 SktSC8 sVLP. Wt residues are shown as sticks colored orange, with mutated residues observed in the 3.6 Å cryo-EM map as green. Cryo-EM density maps are contoured at 1.0σ. b Cartoon representation of the asymmetric unit for the PV3 SktSC8 sVLP. Individual subunits of the protomer are colored blue (VP1), green (VP2), red (VP3) and yellow (VP4). Mutations are shown as spheres and colored magenta. The position of the GPP3 molecule observed bound to the VP1 protein pocket of the 4.1 Å structure of PV3 SktSC8 sVLP is shown as orange spheresCC BY · PubMed Central
Fig. 5 Antigenicity of plant-produced PV3 VLPs. a Reactivity of VLPs and IPV with MAb 520 (D antigen) and MAb 517 (C antigen) in ELISA. The prefix r denotes recombinantly expressed in plants and v denotes expressed from full-length viral construct following electroporation of L cells. b Thermostability of sVLPs. D antigen reactivity of sVLPs and IPV was assessed by ELISA after incubation at different temperatures for 10 min
Fig. 5 Antigenicity of plant-produced PV3 VLPs. a Reactivity of VLPs and IPV with MAb 520 (D antigen) and MAb 517 (C antigen) in ELISA. The prefix r denotes recombinantly expressed in plants and v denotes expressed from full-length viral construct following electroporation of L cells. b Thermostability of sVLPs. D antigen reactivity of sVLPs and IPV was assessed by ELISA after incubation at different temperatures for 10 minCC BY · PubMed Central
Fig. 6 Seroconversion and protection against challenge induced by sVLPs. Transgenic mice expressing the human PV receptor were immunized intraperitoneally once or twice (2×) with PBS or 0.5 human dose equivalents of IPV or sVLPs (recombinant—“r” or viral construct—“v” expressed) then challenged intramuscularly with wt virus. Graph shows neutralizing antibody titers against PV3 in blood samples taken the day prior to challenge and survival rates following challenge with wt PV3 Saukett. Bars indicate 95% confidence interval (CI) of the geometric mean titer
Fig. 6 Seroconversion and protection against challenge induced by sVLPs. Transgenic mice expressing the human PV receptor were immunized intraperitoneally once or twice (2×) with PBS or 0.5 human dose equivalents of IPV or sVLPs (recombinant—“r” or viral construct—“v” expressed) then challenged intramuscularly with wt virus. Graph shows neutralizing antibody titers against PV3 in blood samples taken the day prior to challenge and survival rates following challenge with wt PV3 Saukett. Bars indicate 95% confidence interval (CI) of the geometric mean titerCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Research works printed but not linked: 2

  1. Landsteiner, K. & Popper, E. Übertragung der Poliomyelitis acuta auf Affen. Z. Immunitätsforsch. 2, 377–390 (1909).
  2. Holland, J. J. & Kiehn, E. D. Specific cleavage of viral proteins as steps in the synthesis and maturation of enteroviruses. Proc. Natl. Acad. Sci. USA 60, 1015–22 (1968). · DOI · Paper page

Cited by

See all 127

Metadata

Authors
Marsian, J., Fox, H., Bahar, M. W., Kotecha, A., Fry, E. E., Stuart, D. I., Macadam, A. J., Rowlands, D. J., & Lomonossoff, G. P.
Affiliations
  • John Innes Centre (GB)
  • National Institute for Biological Standards and Control (GB)
  • University of Oxford (GB)
  • Diamond Light Source (GB)
  • University of Leeds (GB)
Corresponding author
Lomonossoff, George P.
Venue
Nature Communications
Published
2017-08-15
Volume
8
Issue
1
Pages
245-245
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2744985300
Cited by
121
References
49
Citations by year
2026: 9 · 2025: 11 · 2024: 19 · 2023: 15 · 2022: 15 · 2021: 12 · 2020: 18 · 2019: 11 · 2018: 8 · 2017: 2
FWCI
7.82
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Bill and Melinda Gates Foundation (RG.IMCB.I8-TSA-083)
  • Wellcome Trust (060208/Z/00/Z, 090532, 093305, 093305/Z/10/Z, 090532/Z/07/Z)
  • Diamond Light Source
  • University of Oxford
  • University of Leeds
  • University of Reading
  • John Innes Foundation (060208/Z/00/Z)
  • Universität Innsbruck
  • Directorate for Biological Sciences
  • Medical Research Council (MR/N00065X/1, 093305/Z/10/Z, 060208/Z/00/Z)
  • Biotechnology and Biological Sciences Research Council (BBS/E/J/00000166, BBS/E/J/000PR9794)
  • Institute of Molecular and Cell Biology
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Transgenic Plants and Applications
  • Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
Keywords
poliovirus type 3, virus-like particles, plant-made vaccines, poliomyelitis, poliovirus receptor, transgenic mice, vaccine development
MeSH terms
Animals, Antibodies, Viral, Female, Humans, Male, Poliomyelitis, Nicotiana, Gene Expression, Poliovirus, Poliovirus Vaccines, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Plant-made polio type 3 stabilized VLPs-a candidate synthetic polio vaccine. https://app.cochat.ai/papers/10.1038/s41467-017-00090-w
The paper
Marsian, J., Fox, H., Bahar, M. W., Kotecha, A., Fry, E. E., Stuart, D. I., Macadam, A. J., Rowlands, D. J., & Lomonossoff, G. P. (2017). Plant-made polio type 3 stabilized VLPs-a candidate synthetic polio vaccine. Nature Communications. https://doi.org/10.1038/s41467-017-00090-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.